Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
Condition: Ebola Virus DiseaseInterventions: Biological: Ebola Vaccine - low dose; Biological: Ebola Vaccine - mid dose; Biological: Ebola Vaccine - high dose; Biological: PlaceboSponsors: Profectus BioSciences, Inc.; Accelovance; United States Department of DefenseRecruiting - verified March 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials